Trials / Completed
CompletedNCT01382407
Does Acne Rash During Adolescence Predict Skin Reaction to Cetuximab
Does Acne Rash During Adolescence Predict Skin Reaction to Cetuximab?
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The hypothesis of this study is that patients who suffered from acne vulgaris during adolescence are at greater risk of developing acneiform skin rash due to cetuximab.
Detailed description
The hypothesis of this study is that patients who suffered from acne vulgaris during adolescence are at greater risk of developing acneiform skin rash due to cetuximab
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cetuximab | Once a week:Loading dose-400 mg/m2;subsequent-250 mg/m2 on days 8,15, 22,29,36 if administered as a single agent, or together with Irinotecan 125 mg/m2 on days 1,8,15,29 followed by administration every 42 days. |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2017-04-01
- Completion
- 2017-04-01
- First posted
- 2011-06-27
- Last updated
- 2017-04-27
Locations
2 sites across 1 country: Israel
Source: ClinicalTrials.gov record NCT01382407. Inclusion in this directory is not an endorsement.